Little Journey raises £6m in Series A funding led by Par Equity to scale global operations.
The Series A financing was led by Par Equity to support international expansion and product development.
Little Journey develops digital health solutions designed to support children and their caregivers through medical procedures and clinical trials. The company provides a cloud-based mobile platform used across NHS hospitals and life sciences organisations.
Little Journey has raised £6m in Series A funding to scale its global operations and enhance its product capabilities. The investment round was led by Par Equity, with participation from Mercia Ventures, the Northern Powerhouse Investment Fund, Octopus Ventures, Calm/Storm Ventures, and angel investors. The company intends to direct the capital toward international expansion, particularly targeting the US healthcare market, alongside developing its data collection and interoperability functions.
From the founder
"Securing this investment allows us to scale our impact across healthcare and life sciences, with a focus on easing the burden of paediatric clinical trials. While legislation like RACE, SPCs, and the ODA has increased study numbers, specialist paediatric knowledge is still lacking in the industry. This has led to lower recruitment, adherence and trial completion rates compared to adult research. Little Journey is uniquely positioned to fill this expertise gap and tackle these challenges to advance global paediatric medicine. With the backing of Par Equity, Mercia Ventures, Octopus Ventures, and our wider investor network, we’re redefining how paediatric clinical trials are run and putting families at the heart of them."
Chris Evans
Co-Founder and CEO at Little Journey
Investor perspective
"Healthtech is at the heart of what we do at Par Equity. We are committed to supporting high-growth, impactful health tech companies that have the potential to revolutionise the way that care is delivered. At present, there exists a pressing need for bespoke technologies tailored to children and Little Journey’s innovative approach to paediatric care does just that. We look forward to seeing what’s in store for the future of children’s healthcare and are excited to support Little Journey’s expansion into the US and beyond."
Elizabeth Young
Investment Manager, Par Equity
Use of funds
- 01Expand into international markets
- 02Continue product development
- 03Build out infrastructure
Investors
Elizabeth Young
Par Equity
Mercia Ventures
Northern Powerhouse Investment Fund
Octopus Ventures
Calm/Storm Ventures
Categories
About the company
Little Journey
Digital health platform supporting children and families through medical procedures and clinical trials.